fda recent warning letters

fda recent warning letters

Avoid 5 Hidden Dangers of glp-1 / Weight-Loss Drugs

The five hidden dangers of GLP-1 weight-loss drugs are rare vision loss, high out-of-pocket costs, differing efficacy for post-menopausal women, legal exposure from undisclosed risks, and the need for proactive eye monitoring. Recent FDA alerts link specific batches of Wegovy and Ozempic to permanent visual impairment, prompting patients to verify